Table 4.

Multivariable Cox regression model for overall survival limiting cases diagnosed from 2015 or later (n = 2033)

VariableHR*95% CI*P
Cytogenetic group    
 Neither C1A nor HRCA Ref — .094 
 HRCA present/no C1A 1.35 0.95-1.92 .029 
 C1A present/no HRCA 1.34 1.03-1.75 <.001 
 Both C1A and HRCA present 2.08 1.47-2.94  
Age, y 1.02 1.01-1.03 .006 
Male 1.12 0.90-1.38 .304 
Race/ethnicity    
 Non-Hispanic white Ref — .132 
 Hispanic or Latino 0.67 0.40-1.12 .399 
 Non-Hispanic African American  1.14 0.84-1.53 .944 
 Other 1.01 0.71-1.45 .281 
 Unknown 1.21 0.85-1.72  
M-protein subtype    
 IgG Ref 1.27-2.18 <.001 
 IgA 1.67 1.21-2.09 .001 
 Other 1.59 1.50-3.22 <.001 
 Unknown 2.20   
First-line therapy    
 IMiD + PI based Ref 0.88-1.67 .239 
 IMiD based 1.21 1.25-2.09 <.001 
 PI based 1.61 0.78-1.92 .378 
 Non-IMiD/PI 1.23   
ASCT 0.23 0.15-0.35 <.001 
VariableHR*95% CI*P
Cytogenetic group    
 Neither C1A nor HRCA Ref — .094 
 HRCA present/no C1A 1.35 0.95-1.92 .029 
 C1A present/no HRCA 1.34 1.03-1.75 <.001 
 Both C1A and HRCA present 2.08 1.47-2.94  
Age, y 1.02 1.01-1.03 .006 
Male 1.12 0.90-1.38 .304 
Race/ethnicity    
 Non-Hispanic white Ref — .132 
 Hispanic or Latino 0.67 0.40-1.12 .399 
 Non-Hispanic African American  1.14 0.84-1.53 .944 
 Other 1.01 0.71-1.45 .281 
 Unknown 1.21 0.85-1.72  
M-protein subtype    
 IgG Ref 1.27-2.18 <.001 
 IgA 1.67 1.21-2.09 .001 
 Other 1.59 1.50-3.22 <.001 
 Unknown 2.20   
First-line therapy    
 IMiD + PI based Ref 0.88-1.67 .239 
 IMiD based 1.21 1.25-2.09 <.001 
 PI based 1.61 0.78-1.92 .378 
 Non-IMiD/PI 1.23   
ASCT 0.23 0.15-0.35 <.001 

HRCA is defined as presence of 1 of the following: del(17p), t4;14, or t14;16).

*

HRs and 95% CIs were derived from a multivariable Cox proportional hazards regression model; all variables in the table were included in the same model simultaneously.

or Create an Account

Close Modal
Close Modal